Republished: Rifampicin induced shock during re-exposure for treatment of latent tuberculosis

Drug Ther Bull. 2020 Oct;58(10):157-159. doi: 10.1136/dtb.2020.232117rep. Epub 2020 Jun 20.

Authors

Christopher Francis Harlow¹, Jamilah Meghji^{2

3}, Laura Martin², Timothy Harris², Onn Min Kon^{2

4}

Affiliations

¹ Department of Chest and Allergy, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK cfharl@aol.com.
² Department of Chest and Allergy, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.
³ Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
⁴ National Heart and Lung Institute, Imperial College London, London, UK.

PMID: 32563996
DOI: 10.1136/dtb.2020.232117rep

No abstract available

Keywords: drugs: infectious diseases; drugs: respiratory system; infections; tuberculosis; unwanted effects/adverse reactions.

Publication types

Corrected and Republished Article

Grants and funding

MR/S02042X/1/MRC_/Medical Research Council/United Kingdom